Avalo Therapeutics, Inc. ($AVTX)
Doyle Mittie โ Chief Medical Officer
Shares
679
Price
$8.04
Total Value
$5,459.16
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Doyle Mittie |
|---|---|
| Title | Chief Medical Officer |
| Transaction Date | May 5, 2026 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | May 7, 2026 |
| Shares Purchased | 679 |
| Price per Share | $8.04 |
| Total Value | $5,459.16 |
| Shares Owned After | 5,301 |
| Derivative | No |
| Accession Number | 0001918845-26-000010 |
| Document | View SEC Filing |